Monte Rosa Therapeutics, Inc.
GLUE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826457
In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Monte Rosa Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 48 | +48 |
| Shares | 0 | 32.1M | +32.1M |
| Value | $0 | $705.1M | +$705.1M |
New holders (48)
Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (0)
Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.